NeuroBo Pharmaceuticals (NRBO) Misses Q2 EPS by 185c
Tweet
Share
E-mailGet Alerts NRBO Hot Sheet
Join SI Premium – FREE
NeuroBo Pharmaceuticals (NASDAQ: NRBO) reported Q2 EPS of ($1.85).
For earnings history and earnings-related data on NeuroBo Pharmaceuticals (NRBO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Financial Group (JEF) Tops Q3 EPS by 8c
- Pathfinder Bancorp (PBHC) Declares $0.10 Quarterly Dividend; 2.3% Yield
- Vail Resorts (MTN) Tops Q4 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
